Notice of Results

e-Therapeutics plc

Notice of Preliminary Results

e-Therapeutics plc (AIM: ETX), the biotechnology company with a proprietary platform in network pharmacology, will be announcing its final results for the 12 month period ending 31st January 2012 on Tuesday 22nd May 2012.

Professor Malcolm Young, CEO, Daniel Elger, CFO, and Stephen Self, Development Director, will be hosting an analyst presentation in London on the morning of the results. Please contact College Hill if you are interested in attending the meeting.

-Ends-

For more information, please contact:

e-Therapeutics plc

Malcolm Young / Daniel Elger

Tel: +44 (0) 7909 915 068

www.etherapeutics.co.uk 

Panmure Gordon (UK) Limited

Andrew Burnett / Fred Walsh

Tel: +44 (0) 20 7459 3600

www.panmure.com

College Hill

Melanie Toyne Sewell / Jayne Crook

Tel: +44 (0) 20 7457 2020

Email: e-therapeutics@collegehill.com